Current Issue
Data as an Asset: What Does this Mean to You?
Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning, The Janssen Pharm...
Developing a Leading Edge with PAT
Martin Gadsby, Owner, Optimal Industrial Automation Ltd
Risk-Based Extractable Data Assessment and its Application to the Evaluation of Materials ...
Ping Wang Ph.D., MBA, Scientific Director, Janssen
Supply Chain Security Risks
Brian Johnson, Senior Director of Supply Chain Security, Pfizer Pharmaceuticals / Chair o...
Applications of SFC in Pharmaceutical Analysis
Gregory Webster, Senior Principal Research Scientist, AbbVie Inc
Transforming Scientists into Drug Developers
Clive Glover, General Manager, Gene Therapy, Pall James Taylor, Co-founder and GM, Precisi...
Featured Articles
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Coupling single-pass TFF before loading onto a chromatography sorbent
View All Featured ArticlesCareers
Inspiring the Next Generation at Bristol Myers Squibb
Elizabeth Jurica, Bristol Myers Squibb, Principal Scientist
A Great Working Atmosphere, Strong Collegial Relationships, and Opportunities to Grow at Lonza
Vijetha Bhat, Lonza, Houston,Texas, Scientist, Research and Development
At Bayer We Foster an Environment of Openness and Understanding Not Pity
Jürgen Schrapp, Bayer, Head of R&D Procurement
The Best Thing About Evotec, Without Question, Is The People
Stuart Flanagan, Evotec, Group Leader
At Boehringer Ingelheim, I am a Molecular Architect…
Alexander M. Haydl, Boehringer Ingelheim Germany, Head of Late-Stage Development Laboratory and Product Owner of Digital Process Development
We Support each other to Develop and Grow at Novartis
Jennifer Snyder, Novartis Pharmaceuticals, Director, Portfolio Strategy Management for Technical Research and Development Cell & Gene Therapy
View All Careers ArticlesHeadline News
FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV
FDA approves Lilly’s Mounjaro™ injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes
Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab)
Read All Headlines
Upcoming Webinars
ICH Q3E Impurity Guidelines: Assessment and Control of Extractractables and Leachables for Pharmaceuticals and Biologics.
Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Piet Christiaens, PhD, Scientific Director at Nelson Labs
14th September 2022
Batch to Continuous Technology: The Journey from Laboratory to Pilot Scale for DS Manufacturing
Presented by Jörg Sedelmeier, Platform Leader: Continuous flow technology (Principal Scientist) at Roche
26th September 2022
Best Practices of Downstream Protein Purification and Product Concentration
Presented by Krishnamurthy Venkatesan, Downstream MSAT Lead, Director at Biocon Biologics.
12th October 2022
View All Upcoming Webinars
Past Webinars
Validation Of Endotoxin Testing For CAR T-cell Manufacturing Quality Control & Benefits of Cartridge Technology
Presented by Dr. Zlatibor Velickovic PhD Production Manager | Department of Cell & Molecular Therapies, Royal Prince Alfred Hospital Sydney, Australia, ISCT Regional Vice-President Elect, Australia & New Zealand and Alan Hoffmeister Senior Global Technology & Market Development Manager, Charles River Laboratories
28th October 2021
Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence?
Presented by Petra Booij, Investigator at GlaxoSmithKline and Dr Kyle D’Silva, Pharma & BioPharma Marketing Leader, Thermo Fisher Scientific
30th January 2020
Challenges and Risks in Development and Manufacture of Covid 19 Vaccines
Presented by Rajesh K. Gupta, Ph.D. Biologics Quality & Regulatory Consultants, LLC, North Potomac, Harish Rao, General Manager at Serum Institute of India Ltd, Amar Shrivastava, Senior Manager at Serum Institute of India Ltd
30th June 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Lifetime study for JSR Amsphere A3 – protein A resin
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Amsphere TM A3
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products